Immunosuppression and Human Malignancy

por Robins, R.A.
Publicado 1991

Serum antibody responses to an ascitic variant of rat hepatoma D23.

por Robins, R. A.
Publicado 1975

Tumour-derived lymphoid cells prevent tumour growth in Winn assays.

por Robins, R. A., Flannery, G. R., Baldwin, R. W.
Publicado 1979

Spontaneous development of cytotoxic activity in cultured lymphnode cells from tumour-bearing rats.

por Robins, R. A., Rees, R. C., Brooks, C. G., Baldwin, R. W.
Publicado 1979

Modification of the immunogenicity and antigenicity of rat hepatoma cells. I. Cell-surface stabilization with glutaraldehyde.

por Price, M. R., Dennick, R. G., Robins, R. A., Baldwin, R. W.
Publicado 1979

Recombinant ricin toxin A chain cytotoxicity against carcinoembryonic antigen expressing tumour cells mediated by a bispecific monoclonal antibody and its potentiation by ricin tox...

por Embleton, M. J., Charleston, A., Robins, R. A., Pimm, M. V., Baldwin, R. W.
Publicado 1991

Circulating immune complexes in dogs with osteosarcoma.

por Segal-Eiras, A., Robins, R. A., Hannant, D., Owen, L. N., Baldwin, R. W.
Publicado 1982

Flow cytometric analysis of the DNA content of gastric cancer.

por Ballantyne, K. C., James, P. D., Robins, R. A., Baldwin, R. W., Hardcastle, J. D.
Publicado 1987

Enhanced recognition of human colorectal tumour cells using combinations of monoclonal antibodies.

por Durrant, L. G., Robins, R. A., Ballantyne, K. C., Marksman, R. A., Hardcastle, J. D., Baldwin, R. W.
Publicado 1989

A bispecific monoclonal antibody against methotrexate and a human tumour associated antigen augments cytotoxicity of methotrexate-carrier conjugate.

por Pimm, M. V., Robins, R. A., Embleton, M. J., Jacobs, E., Markham, A. J., Charleston, A., Baldwin, R. W.
Publicado 1990

Quantitation of MHC antigen expression on colorectal tumours and its association with tumour progression.

por Durrant, L. G., Ballantyne, K. C., Armitage, N. C., Robins, R. A., Marksman, R., Hardcastle, J. D., Baldwin, R. W.
Publicado 1987

Antigenicity of newly established colorectal carcinoma cell lines.

por Durrant, L. G., Robins, R. A., Pimm, M. V., Perkins, A. C., Armitage, N. C., Hardcastle, J. D., Baldwin, R. W.
Publicado 1986

c-myc oncogene product expression and prognosis in operable breast cancer.

por Locker, A. P., Dowle, C. S., Ellis, I. O., Elston, C. W., Blamey, R. W., Sikora, K., Evan, G., Robins, R. A.
Publicado 1989

Tumour aneuploidy, prognostic parameters and survival in primary breast cancer.

por Owainati, A. A., Robins, R. A., Hinton, C., Ellis, I. O., Dowle, C. S., Ferry, B., Elston, C. W., Blamey, R. W., Baldwin, R. W.
Publicado 1987

Randomized double-blind phase II survival study comparing immunization with the anti-idiotypic monoclonal antibody 105AD7 against placebo in advanced colorectal cancer

por Maxwell-Armstrong, C A, Durrant, L G, Buckley, T J D, Scholefield, J H, Robins, R A, Fielding, K, Monson, J R T, Guillou, P, Calvert, H, Carmichael, J, Hardcastle, J D
Publicado 2001

Effects of pro‐inflammatory cytokines on cannabinoid CB (1) and CB (2) receptors in immune cells

por Jean‐Gilles, L., Braitch, M., Latif, M. L., Aram, J., Fahey, A. J., Edwards, L. J., Robins, R. A., Tanasescu, R., Tighe, P. J., Gran, B., Showe, L. C., Alexander, S. P., Chapman, V., Kendall, D. A., Constantinescu, C. S.
Publicado 2015